PMD-026 Reduces Triple Negative Breast Cancer Growth, Mice Study Shows
News
PMD-026 reduced tumor growth in mice with triple negative breast cancer (TNBC), according to its developer, Phoenix Molecular Designs. The therapy, which targets the RSK family of enzymes associated with cancer ... Read more